Teva Pharmaceutical Industries Ltd. — Remuneration Information 2013

Jun 19, 2013

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7947Corporation no: 520013954Stock Exchange/Market: NYSE310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: tomer.amitai@teva.co.ilDate of transmission: 19/06/2013              Time of broadcast: 09:10 08:42:42

Reference: 2013-02-067971

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva to Disclose Executive Compensation as of its 2013 Annual Report Announces Settlement of Related Class Action Lawsuit.
discloseofexecutivecompensation_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 11/06/2013
- - -
Name of the Signatory: : Egosi Richard , Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary , Name of Employer Company: .
Basel Telephone: 03-9267513 , Facsimile: 03-9267429 , E-mail: richard.egosi@teva.co.il 2